TWI812918B - IL-7Rαγc結合化合物 - Google Patents
IL-7Rαγc結合化合物 Download PDFInfo
- Publication number
- TWI812918B TWI812918B TW110104084A TW110104084A TWI812918B TW I812918 B TWI812918 B TW I812918B TW 110104084 A TW110104084 A TW 110104084A TW 110104084 A TW110104084 A TW 110104084A TW I812918 B TWI812918 B TW I812918B
- Authority
- TW
- Taiwan
- Prior art keywords
- ligand
- 7rαγc
- seq
- amino acid
- ligands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5418—IL-7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062969432P | 2020-02-03 | 2020-02-03 | |
| US62/969,432 | 2020-02-03 | ||
| US202063041158P | 2020-06-19 | 2020-06-19 | |
| US63/041,158 | 2020-06-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202144390A TW202144390A (zh) | 2021-12-01 |
| TWI812918B true TWI812918B (zh) | 2023-08-21 |
Family
ID=77200524
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW110104084A TWI812918B (zh) | 2020-02-03 | 2021-02-03 | IL-7Rαγc結合化合物 |
| TW112126553A TW202342505A (zh) | 2020-02-03 | 2021-02-03 | IL-7Rαγc結合化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW112126553A TW202342505A (zh) | 2020-02-03 | 2021-02-03 | IL-7Rαγc結合化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11746139B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4100427A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023514128A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220139918A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115315435A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2021217353A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022015002A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3166816A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL295304A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022009390A (cg-RX-API-DMAC7.html) |
| TW (2) | TWI812918B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021158623A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210055694A (ko) | 2018-08-06 | 2021-05-17 | 메디카인 인코포레이티드 | Il-2 수용체 결합 화합물 |
| CA3160466A1 (en) | 2019-11-05 | 2021-05-14 | Medikine, Inc. | Dual il-2r and il-7r binding compounds |
| MX2022005411A (es) | 2019-11-05 | 2022-08-10 | Medikine Inc | COMPUESTOS DE UNIÓN A IL-2RßYC. |
| US11746139B2 (en) * | 2020-02-03 | 2023-09-05 | Medikine, Inc. | IL-7Rαγc binding compounds |
| AU2021217959A1 (en) * | 2020-02-03 | 2022-08-18 | Medikine, Inc. | IL-7Rα binding compounds |
| EP4240394A4 (en) * | 2020-11-04 | 2024-10-23 | Medikine, Inc. | IL-2R BETA-GAMMA C-BINDING COMPOUNDS AND USES THEREOF |
| US20250082777A1 (en) | 2022-01-10 | 2025-03-13 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2023193015A1 (en) | 2022-04-01 | 2023-10-05 | Sana Biotechnology, Inc. | Cytokine receptor agonist and viral vector combination therapies |
| US11999771B2 (en) | 2022-04-07 | 2024-06-04 | Medikine, Inc. | IL-7Rαγc ligand immunoglobulin fusion proteins |
| US20240101959A1 (en) | 2022-09-06 | 2024-03-28 | Medikine, Inc. | Use of il-2r-beta-gamma agonist peptides in cell manufacturing |
| US20240100159A1 (en) | 2022-09-06 | 2024-03-28 | Medikine, Inc. | Use of il-7r-alpha-gamma agonist peptides in cell manufacturing |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130330296A1 (en) * | 2010-12-10 | 2013-12-12 | University Of Central Florida Research Foundation, Inc. | Methods and Compositions Comprising IL-7 Receptor Ligands |
| TW201713699A (zh) * | 2015-08-06 | 2017-04-16 | 新加坡科技研究局 | 介白素2受體β(IL2Rβ)/共同γ鏈抗體 |
| TW201833137A (zh) * | 2016-12-09 | 2018-09-16 | 法商Ose免疫療法公司 | 靶向cd127之抗體和多肽 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5635597A (en) | 1994-05-27 | 1997-06-03 | Affymax Technologies, N.V. | Peptides that bind IL-2 receptors |
| EP1454138B1 (en) | 2001-12-04 | 2012-01-18 | Merck Patent GmbH | Immunocytokines with modulated selectivity |
| US20050054054A1 (en) * | 2002-11-12 | 2005-03-10 | Foss Francine M. | Interleukin-7 molecules with altered biological properties |
| KR101163424B1 (ko) | 2003-12-30 | 2012-07-13 | 메르크 파텐트 게엠베하 | Il-7 융합 단백질 |
| CN101072793B (zh) | 2004-12-09 | 2012-06-20 | 默克专利有限公司 | 具有降低的免疫原性的il-7变体 |
| EP1828231A2 (en) | 2004-12-22 | 2007-09-05 | Novartis Vaccines and Diagnostics, Inc. | Group b streptococcus |
| US20120210458A9 (en) | 2009-02-27 | 2012-08-16 | Yongwei Cao | Isolated Novel Nucleic Acid and Protein Molecules from Corn and Methods of Using Thereof |
| ES2866674T3 (es) | 2010-11-12 | 2021-10-19 | Nektar Therapeutics | Conjugados de una fracción de IL-2 y un polímero |
| CA2824515C (en) | 2011-01-18 | 2022-09-13 | Bioniz, Llc | Compositions and methods for modulating gamma-c-cytokine activity |
| JP6592505B2 (ja) | 2014-04-24 | 2019-10-16 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | インターロイキン−2のスーパーアンタゴニスト、パーシャルアゴニスト及びアンタゴニスト |
| KR102493543B1 (ko) | 2014-07-21 | 2023-01-30 | 데리니아, 인크. | 자가면역 질환의 치료를 위한 조절 t 세포를 선택적으로 활성화시키는 분자 |
| JP6640834B2 (ja) | 2014-08-11 | 2020-02-05 | デリニア, インコーポレイテッド | 自己免疫疾患の処置のために調節性t細胞を選択的に活性化させる改変il−2変異体 |
| KR102908806B1 (ko) | 2015-10-22 | 2026-01-07 | 주노 테라퓨틱스 게엠베하 | 세포의 배양 방법 및 이를 위한 키트와 장치 |
| US20170204154A1 (en) | 2016-01-20 | 2017-07-20 | Delinia, Inc. | Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseases |
| US11053293B2 (en) | 2016-02-05 | 2021-07-06 | Washington University | Compositions and methods for targeted cytokine delivery |
| EP3538548A4 (en) | 2016-11-08 | 2020-08-19 | Delinia, Inc. | IL-2 VARIANTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES |
| CN110177564A (zh) | 2016-12-13 | 2019-08-27 | 德里尼亚公司 | 多价的调节t细胞调节剂 |
| KR20210055694A (ko) | 2018-08-06 | 2021-05-17 | 메디카인 인코포레이티드 | Il-2 수용체 결합 화합물 |
| WO2020247388A2 (en) | 2019-06-03 | 2020-12-10 | Medikine, Inc. | Il-2alpha receptor subunit binding compounds |
| MX2022005411A (es) | 2019-11-05 | 2022-08-10 | Medikine Inc | COMPUESTOS DE UNIÓN A IL-2RßYC. |
| US20220119492A1 (en) | 2019-11-05 | 2022-04-21 | Medikine, Inc. | Il-2r-beta-gamma binding compounds and uses thereof |
| CA3160466A1 (en) | 2019-11-05 | 2021-05-14 | Medikine, Inc. | Dual il-2r and il-7r binding compounds |
| TW202136287A (zh) | 2019-12-17 | 2021-10-01 | 法商Ose免疫治療公司 | 包含il-7變體之雙官能分子 |
| AU2021217959A1 (en) | 2020-02-03 | 2022-08-18 | Medikine, Inc. | IL-7Rα binding compounds |
| US11746139B2 (en) | 2020-02-03 | 2023-09-05 | Medikine, Inc. | IL-7Rαγc binding compounds |
| EP4240394A4 (en) | 2020-11-04 | 2024-10-23 | Medikine, Inc. | IL-2R BETA-GAMMA C-BINDING COMPOUNDS AND USES THEREOF |
| US11999771B2 (en) | 2022-04-07 | 2024-06-04 | Medikine, Inc. | IL-7Rαγc ligand immunoglobulin fusion proteins |
-
2021
- 2021-02-03 US US17/166,462 patent/US11746139B2/en active Active
- 2021-02-03 CA CA3166816A patent/CA3166816A1/en active Pending
- 2021-02-03 EP EP21750982.7A patent/EP4100427A4/en not_active Withdrawn
- 2021-02-03 TW TW110104084A patent/TWI812918B/zh not_active IP Right Cessation
- 2021-02-03 BR BR112022015002A patent/BR112022015002A2/pt not_active IP Right Cessation
- 2021-02-03 JP JP2022547164A patent/JP2023514128A/ja active Pending
- 2021-02-03 WO PCT/US2021/016361 patent/WO2021158623A1/en not_active Ceased
- 2021-02-03 MX MX2022009390A patent/MX2022009390A/es unknown
- 2021-02-03 AU AU2021217353A patent/AU2021217353A1/en not_active Abandoned
- 2021-02-03 TW TW112126553A patent/TW202342505A/zh unknown
- 2021-02-03 CN CN202180022881.5A patent/CN115315435A/zh not_active Withdrawn
- 2021-02-03 IL IL295304A patent/IL295304A/en unknown
- 2021-02-03 KR KR1020227030327A patent/KR20220139918A/ko not_active Withdrawn
-
2023
- 2023-07-11 US US18/350,543 patent/US11965015B2/en active Active
-
2024
- 2024-03-21 AU AU2024201860A patent/AU2024201860A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130330296A1 (en) * | 2010-12-10 | 2013-12-12 | University Of Central Florida Research Foundation, Inc. | Methods and Compositions Comprising IL-7 Receptor Ligands |
| TW201713699A (zh) * | 2015-08-06 | 2017-04-16 | 新加坡科技研究局 | 介白素2受體β(IL2Rβ)/共同γ鏈抗體 |
| TW201833137A (zh) * | 2016-12-09 | 2018-09-16 | 法商Ose免疫療法公司 | 靶向cd127之抗體和多肽 |
Non-Patent Citations (1)
| Title |
|---|
| 網路文獻 Carmen Burtea et al, "Screening for peptides targeted to IL-7Rα for molecular imaging of rheumatoid arthritis synovium", Arthritis Res Ther. 2016 Oct 12;18(1):230. * |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220139918A (ko) | 2022-10-17 |
| MX2022009390A (es) | 2022-11-16 |
| US20230357358A1 (en) | 2023-11-09 |
| TW202342505A (zh) | 2023-11-01 |
| AU2021217353A1 (en) | 2022-08-25 |
| CN115315435A (zh) | 2022-11-08 |
| CA3166816A1 (en) | 2021-08-12 |
| IL295304A (en) | 2022-10-01 |
| JP2023514128A (ja) | 2023-04-05 |
| WO2021158623A1 (en) | 2021-08-12 |
| EP4100427A4 (en) | 2024-01-17 |
| US11746139B2 (en) | 2023-09-05 |
| AU2024201860A1 (en) | 2024-05-16 |
| US11965015B2 (en) | 2024-04-23 |
| TW202144390A (zh) | 2021-12-01 |
| US20210253670A1 (en) | 2021-08-19 |
| BR112022015002A2 (pt) | 2022-12-06 |
| EP4100427A1 (en) | 2022-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11965015B2 (en) | IL-7R-α-γ binding compounds | |
| TWI823054B (zh) | IL-7Rα結合化合物 | |
| US11248030B2 (en) | Dual IL-2R and IL-7R binding compounds | |
| US20230331801A1 (en) | Il-2r-beta-gamma binding compounds | |
| EP4268901A2 (en) | Il-2r beta-gamma c binding compounds and uses thereof | |
| US20220119492A1 (en) | Il-2r-beta-gamma binding compounds and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |